Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_6FD3B35B8A79
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
Journal
Journal of Allergy and Clinical Immunology
Author(s)
Spertini F., Perrin Y., Audran R., Pellaton C., Boudousquié C., Barbier N., Thierry A.C., Charlon V., Reymond C.
ISSN
0091-6749, 1097-6825 (Electronic)
Publication state
Published
Issued date
2014
Volume
134
Number
1
Pages
239-240.e13
Language
english
Notes
Publication types: Clinical Trial, Phase I ; Clinical Trial, Phase II ; Letter ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Keywords
Adult, Antigens, Plant/chemistry, Antigens, Plant/immunology, Asthma/immunology, Asthma/therapy, Conjunctivitis, Allergic/immunology, Conjunctivitis, Allergic/therapy, Desensitization, Immunologic/methods, Female, Humans, Immunization Schedule, Immunoglobulin E/blood, Immunoglobulin G/blood, Immunologic Memory, Injections, Subcutaneous, Middle Aged, Peptides/administration & dosage, Peptides/adverse effects, Rhinitis, Allergic/immunology, Rhinitis, Allergic/therapy
OAI-PMH
oai:serval.unil.ch:BIB_6FD3B35B8A79
DOI
10.1016/j.jaci.2014.04.001
Pubmed
24797422
Web of science
000338930300036
Create date
20/01/2015 18:48
Last modification date
20/08/2019 14:28
Usage data